Exai Bio Inc.
Biotechnology company · Palo Alto, California, United States
Exai Bio Inc. is a biotechnology company headquartered in Palo Alto, California, United States. Its earliest recorded incorporation is in 2021. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $1.3 million in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $71 million sold in a notice filed in 2022.
Exai Bio at a glance
What does Exai Bio do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $1.3 million in total (2024). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $70.6 million sold (2022).
Frequently asked questions about Exai Bio
Where is Exai Bio headquartered?
Exai Bio Inc. is headquartered in Palo Alto, California, United States.
What does Exai Bio do?
Exai Bio Inc. is a biotechnology company.
When was Exai Bio founded?
The earliest incorporation on record for Exai Bio Inc. is in 2021, according to public company registers.
Similar companies
- Kodiak Sciences Inc.Palo Alto, California, United States
- Scilex Holding CoPalo Alto, California, United States
- Immune-Onc Therapeutics, Inc.Palo Alto, California, United States
- Greenstone Biosciences, Inc.Palo Alto, California, United States
- Combinati IncPalo Alto, California, United States
- Eiger BioPharmaceuticals, Inc.Palo Alto, California, United States
- Riboscience LLCPalo Alto, California, United States
- Irenix Medical, Inc.Palo Alto, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-24. Data licences